Skip to main content
. 2018 Nov 12;3(5):625–638. doi: 10.1016/j.jacbts.2018.07.003

Table 1.

Parameters at Baseline and After 4 h for Vehicle and BMS-986231 0.7, 2, and 7 μg/kg/min

Vehicle
LV Function (n = 7)
BMS-986231 (0.7 μg/kg/min)
BMS-986231 (2 μg/kg/min)
BMS-986231 (7 μg/kg/min)
Baseline 4 h (%Δ From Baseline) Baseline 4 h (%Δ From Baseline) Baseline 4 h (%Δ From Baseline) Baseline 4 h (%Δ From Baseline)
HR, beats/min 83 ± 1 82 ± 3 (−2 ± 4) 77 ± 1 76 ± 1 (−2 ± 1) 87 ± 3 86 ± 4 (−1 ± 3) 84 ± 2 84 ± 2 (−0.3 ± 3)
MAP, mm Hg 76 ± 2 73 ± 2 (−4 ± 1) 76 ± 2 72 ± 3 (−5 ± 2) 78 ± 2 76 ± 2 (−1 ± 3) 79 ± 3 70 ± 3 (−11 ± 3)
SAP, mm Hg 89 ± 2 87 ± 2 (−2 ± 0.9) 92 ± 2 89 ± 2 (−3 ± 2) 90 ± 3 89 ± 2 (−1 ± 2) 91 ± 3 86 ± 3 (−6 ± 3)
LVEDP, mm Hg 14 ± 0.4 14 ± 0.6 (0 ± 3) 13 ± 0.5 13 ± 0.6 (−3 ± 3) 14 ± 0.4 13 ± 0.5 (−6 ± 4) 14 ± 0.3 12 ± 0.8 (−14 ± 4)
LVEDV, ml 85 ± 4 84 ± 4 (−1 ± 0.7) 83 ± 5 80 ± 5 (−4 ± 1) 86 ± 4 81 ± 4 (−6 ± 2) 85 ± 4 78 ± 4 (−9 ± 2)
LVESV, ml 61 ± 4 60 ± 4 (−1 ± 1) 58 ± 5 51 ± 4 (−12 ± 0.9) 61 ± 4 50 ± 2 (−18 ± 2) 60 ± 4 48 ± 3 (−19 ± 2)
SV, ml 24 ± 0.9 24 ± 0.8 (0.1 ± 1) 25 ± 1 29 ± 2 (14 ± 3) 25 ± 1 31 ± 2 (23 ± 7) 25 ± 0.9 30 ± 1 (18 ± 2)
CO, l/min 2.01 ± 0.06 1.97 ± 0.07 (−2 ± 5) 1.94 ± 0.07 2.18 ± 0.13 (12 ± 3) 2.20 ± 0.08 2.67 ± 0.16 (22 ± 8) 2.11 ± 0.06 2.47 ± 0.11 (17 ± 5)
LVEF, % 29 ± 1 29 ± 1 (2 ± 1) 31 ± 2 36 ± 2 (18 ± 2) 30 ± 1 38 ± 1 (30 ± 6) 30 ± 0.6 38 ± 0.7 (30 ± 2)
LVFAS, % 28 ± 2 27 ± 2 (−1 ± 2) 27 ± 2 33 ± 2 (25 ± 5) 26 ± 2 35 ± 2 (31 ± 3) 26 ± 2 37 ± 2 (48 ± 8)
Mean aortic flow, ml/s 27 ± 2 27 ± 2 (−0.2 ± 2) 27 ± 2 33 ± 2 (25 ± 6) 27 ± 2 34 ± 3 (24 ± 4) 27 ± 2 36 ± 3 (32 ± 5)
SVR (dynes·s·cm−5) 3,060 ± 141 3,009 ± 120 (−0.5 ± 6) 3,164 ± 170 2,706 ± 165 (−15 ± 3) 2,847 ± 129 2,354 ± 189 (−17 ± 5) 3,002 ± 114 2,298 ± 143 (−23 ± 5)
LV peak +dP/dt, mm Hg/s 1,476 ± 85 1,595 ± 105 (10 ± 10) 1,442 ± 102 1,517 ± 98 (6 ± 4) 1,482 ± 110 1,560 ± 79 (7 ± 5) 1,435 ± 75 1,458 ± 85 (3 ± 6)
Ei/Ai 4.2 ± 0.4 4.1 ± 0.4 (−2 ± 2) 4.1 ± 0.3 5.7 ± 0.6 (41 ± 13) 4.1 ± 0.3 5.8 ± 0.5 (42 ± 4) 3.6 ± 0.4 6.3 ± 0.7 (80 ± 20)
DT, ms 77 ± 2 77 ± 2 (−0.3 ± 2) 75 ± 2 86 ± 2 (14 ± 2) 74 ± 3 87 ± 3 (17 ± 5) 76 ± 2 89 ± 2 (16 ± 2)
LVEDWS, g/cm2 69 ± 6 67 ± 6 (−4 ± 4) 65 ± 7 55 ± 6 (−14 ± 3) 69 ± 8 58 ± 3 (−12 ± 6) 70 ± 5 57 ± 4 (−19 ± 4)
MVO2, μmol/min NT NT 52 ± 12 61 ± 13 (13 ± 5) NT NT 170 ± 11 97 ± 7 (−42 ± 5)

Values are mean ± SEM.

Δ = change; CO = cardiac output; DT = deceleration time of early mitral inflow velocity; Ei/Ai = ratio of Ei (time−velocity integral of the mitral inflow velocity waveform representing early filling) to Ai (time−velocity integral representing left atrial contraction); HR = heart rate; LV = left ventricular; LVEDP = LV end-diastolic pressure; LVEDV = LV end-diastolic volume; LVEDWS = LV end-diastolic circumferential wall stress; LVEF = LV ejection fraction; LVESV = LV end-systolic volume; LVFAS = LV fractional area shortening; LV peak +dP/dt = peak rate of change of LV pressure during isovolumic contraction; MAP = mean arterial pressure; MVO2 = myocardial oxygen consumption; NT = not tested; SAP = systolic arterial pressure; SV = stroke volume; SVR = systemic vascular resistance.

p < 0.05 vs. baseline.

p < 0.05 vs. 0.7-μg/kg/min dose infusion.

p < 0.05 vs. vehicle.